Sociedad Americana de Hirudoterapia

Leeches and hand surgery: history, physiology, and a scoping review

Chabridon AI, Coquerel-Beghin D, Leger M, Baamir A, Bazeli A, Auquit-Auckbur I (2026) · Hand Surgery and Rehabilitation · n=13

Detalle de evidencia de RCTReferencia del ensayo
GRADE bajaCohorte / serie de casos
Tamaño de muestra de este ensayo en comparación con otros ensayos de venous-congestion-flapMarquard JM 20251215Bishop JL 2023843Doğan S 2024570Troeltzsch M 2016330Kucur C 2015260Wang ZD 2022210Lehnhardt M 202196Kruer RM 201459Mozafari N 201056Chabridon AI 202613
Este ensayo (destacado) por tamaño de muestra junto a otros ensayos indexados de venous-congestion-flap. Los ensayos más grandes generalmente tienen mayor peso estadístico.

Perfil del estudio

Diseño
scoping review using the PRISMA methodology of leech therapy in hand surgery; PubMed and Google Scholar searches from January 2004 to September 2024 using keywords 'hirudotherapy', 'leech therapy', and 'hand surgery'; 55 documents screened, 13 articles selected for analysis (mostly American retrospective studies with 2-15 year follow-up periods); review reviews excluded (Department of Plastic and Hand Surgery, Rouen University Hospital, France)
Tamaño de la muestra (n)
13
Intervención
Synthesis of leech therapy practice in hand surgery from 13 included studies, with descriptive analysis of indications (revascularizations and replantations), treatment duration (typically 1-7 days), application frequency (once a day to every 2 hours), effectiveness rates (approximately 50%), and most frequent complications (infection and anemia requiring repeated transfusions)
Comparador
Not applicable - scoping review of published practice patterns
Punto final primario
Description of the history, physiology, and contemporary use of medicinal leech therapy in hand surgery; identification of effectiveness patterns and complication profiles
Resultado primario
Leech therapy is a frequently used complementary therapy in hand surgery for venous congestion after revascularization and replantation, with approximately 50% effectiveness; treatment duration typically ranges 1-7 days with applications ranging from once a day to every 2 hours; most frequent complications are infection and anemia requiring repeated transfusions; authors conclude that hirudotherapy should be considered an integral part of the therapeutic approach when surgery alone is insufficient for venous congestion management
Duración del seguimiento
follow-up varied by included study (2-15 years for the included American retrospective studies)

Hallazgos clave

  • First comprehensive PRISMA scoping review focused specifically on leech therapy in hand surgery (2004-2024 window)
  • Documents approximately 50% effectiveness rate across 13 included studies — sets realistic salvage expectations for hand surgery applications
  • Identifies infection and transfusion-requiring anemia as the most frequent leech-therapy complications in hand surgery
  • Treatment duration typically 1-7 days with applications from once-daily to every-2-hours — provides practical range for protocol design
  • Adds French (Rouen) academic-center perspective to the broader hand-surgery leech literature, mostly composed of American retrospective studies

Limitaciones

  • Scoping review methodology - does not provide quantitative effectiveness or safety meta-analysis
  • Included studies are uniformly retrospective with no randomized comparators
  • Heterogeneous treatment protocols across included studies — pooled effectiveness estimates may be misleading
  • Reviews of other studies were excluded — possible omission of relevant data
  • Recent 2025-2026 studies (Kameda 2025, Pickrell 2020, Pertea 2021, Sounthakith 2026) may not be fully captured

Implicaciones clínicas

Chabridon 2026 is the most current and methodologically structured scoping review of medicinal leech therapy in hand surgery, documenting approximately 50% effectiveness for venous congestion salvage across 13 published studies. For US clinicians performing hand replantation and revascularization under the K040187-cleared indication, the trial provides realistic salvage expectations and a practical operational range for leech-therapy duration and frequency. The review reinforces the importance of vigilant infection surveillance and transfusion readiness as integral components of K040187 hand-surgery leech-therapy protocols.

Estudios relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.